Effect of Different Discharge Energy on the Efficacy of Transthoracic Cardioversion in Patients With Persistent Atrial Fibrillation

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR1900024500

Enrollment

Unknown

Registered

2019-07-13

Start date

2019-07-01

Completion date

Unknown

Last updated

2019-07-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Persistent Atrial Fibrillation

Interventions

A:100J

B:150J

C:200J

Eligibility

Sex/Gender

All

Age

18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1 Aged 18 to 75 years; 2 Subjects with persistent AF documented by ECG recording and history; 3 Patient willing to sign the informed consent.

Exclusion criteria

Exclusion criteria: 1 Moderate to severe valvular disease; 2 With congenital heart disease; 3 K+ <3.5 mmol/ L. 4 Left atrial diameter = 55 mm; 5 Left ventricular ejection fraction <40%; 6 Significant pulmonary dysfunction; 7 Thrombus in the left atrium despite anticoagulation in therapeutic range; 8 Contraindication to anticoagulation therapy; 9 History of cardiac surgery; 10 Subjects that are pregnant; 11 Life expectancy <12 months; 12 Digitalis intoxication.

Design outcomes

Primary

Measure	Time frame
restore sinus rhythm after first-shock.;	—

Secondary

Measure	Time frame
myocardial injury;complications;	—

Countries

China

Contacts

Public ContactBing Han

Xuzhou Central Hospital

hbing@hotmail.com+86 15305218127

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026